Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds
A study by Casey Halpern of the Perelman School of Medicine finds that Eli Lilly’s GLP-1 weight-loss drug appears to temporarily suppress food-craving signals in the reward center of the brain.